William Blair Has Pessimistic Outlook of HEICO Q2 Earnings
Investment analysts at William Blair decreased their Q2 2025 earnings estimates for HEICO in a research note issued to ...
Palantir's Stock Surges as Wall Street Analyst Says It Could Help DOGE Cut Spending
Palantir shares surged Wednesday as William Blair analysts suggested the company’s software could be well positioned to support Department of Government Efficiency efforts to trim spending.
Palantir stock opens in green: here’s why?
William Blair analyst Louie DiPalma upgraded Palantir’s stock to Market Perform from Underperform on Wednesday, following a ...
Biodesix (NASDAQ:BDSX) Earns Outperform Rating from William Blair
Biodesix (NASDAQ:BDSX – Get Free Report)‘s stock had its “outperform” rating restated by stock analysts at William Blair in a ...
Why Palantir (PLTR) Stock Is Climbing Today
If you are looking for an AI stock that is more promising than PLTR but that trades at less than 5 times its earnings, check ...
Fierce Pharma2d
Sinusitis data from Amgen, AZ's Tezspire spark 'best-in-disease' talk amid Sanofi, GSK competition
Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...
William Blair IM launches EM frontier debt SICAV fund
It will invest in government debt from frontier markets countries across Asia, Latin Am, Eastern Europe, Middle East, Africa ...
Autism care software company CentralReach tapped William Blair to explore a sale
Autism software provider CentralReach has been looking for a potential buyer, according to multiple sources with knowledge of ...